Optimizerx Corporation (OPRX) –
-
Form 4 OptimizeRx Corp For: Feb 15 Filed by: FEBBO WILLIAM J
-
Form 4 OptimizeRx Corp For: Feb 15 Filed by: Besch Doug
-
Form 4 OptimizeRx Corp For: Feb 15 Filed by: Odence-Ford Marion
-
Form 4 OptimizeRx Corp For: Feb 15 Filed by: Stelmakh Edward
-
Form 4 OptimizeRx Corp For: Mar 15 Filed by: Silvestro Stephen L
-
Form 4/A OptimizeRx Corp For: Oct 11 Filed by: Stelmakh Edward
-
Form 4/A OptimizeRx Corp For: Oct 11 Filed by: Stelmakh Edward
-
Form 8-K OptimizeRx Corp For: Apr 16
-
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
-
Form 4 OptimizeRx Corp For: Apr 15 Filed by: FEBBO WILLIAM J
-
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
-
Form 10-K OptimizeRx Corp For: Dec 31
-
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
-
JMP Securities Starts OptimizeRX (OPRX) at Market Outperform, 'Comprehensive Biopharma Digital Marketing Platform'
-
Form 8-K OptimizeRx Corp For: Mar 28
-
Form NT 10-K OptimizeRx Corp For: Dec 31
-
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
-
Form 8-K OptimizeRx Corp For: Mar 11
-
Optimizerx Corporation (OPRX) Reaffirms Prior Guidance, Will Hold Earnings Call on Thursday, March 28, 2024
-
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
-
OptimizeRX (OPRX) PT Raised to $17 at Lake Street Capital Markets
-
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
-
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
-
Form 4 OptimizeRx Corp For: Dec 19 Filed by: Besch Doug
-
Form 4 OptimizeRx Corp For: Dec 19 Filed by: Stelmakh Edward
-
Form 4 OptimizeRx Corp For: Dec 19 Filed by: Odence-Ford Marion
-
Form 4 OptimizeRx Corp For: Dec 19 Filed by: Silvestro Stephen L
-
OptimizeRx to Participate in Upcoming Investor Conferences
-
Form SC 13G OptimizeRx Corp Filed by: First Light Asset Management, LLC
-
Form 4 OptimizeRx Corp For: Feb 11 Filed by: Odence-Ford Marion
-
Form SC 13G/A OptimizeRx Corp Filed by: VANGUARD GROUP INC
-
Form 4 OptimizeRx Corp For: Feb 02 Filed by: KLEMA CATHY
-
Form 3 OptimizeRx Corp For: Jan 24 Filed by: KLEMA CATHY
-
Form SC 13G/A OptimizeRx Corp Filed by: BlackRock Inc.
-
Form 8-K OptimizeRx Corp For: Jan 24
-
OptimizeRX (OPRX) PT Raised to $17 at Lake Street Capital Markets
-
Optimizerx (OPRX) Announces Strategic Board Changes
-
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
-
Form 4 OptimizeRx Corp For: Jan 09 Filed by: FEBBO WILLIAM J
-
Form 4 OptimizeRx Corp For: Jan 09 Filed by: Odence-Ford Marion
-
OptimizeRX (OPRX) PT Raised to $17 at RBC Capital
-
Form 144 OptimizeRx Corp Filed by: Odence-Ford Marion
-
OptimizeRX (OPRX) PT Raised to $14 at Lake Street Capital Markets
-
Optimizerx Corporation (OPRX) Reports Select Prelim FY23 Results, Provides a Business Update
-
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
-
Form 8-K/A OptimizeRx Corp For: Oct 20
-
Barclays Starts OptimizeRX (OPRX) at Equalweight
-
Form SC 13G OptimizeRx Corp Filed by: Divisadero Street Capital Management, LP
-
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
-
Form SC 13G OptimizeRx Corp Filed by: Weintraub Michael
Back to OPRX Stock Lookup